
|
HIV-1
Drug Resistance Profiles in Children and Adults With Viral Load
of < 50 Copies/mL Receiving Combination Therapy [Hemankova
M, et al. JAMA 2001; 286: 196]: This is a report on a study
from Hopkins that was designed to determine the resistance mutations
of HIV-1 strains detected with low level viremia, defined as <50
c/mL during HAART. Viral sequences from 8 patients were amplified,
and this showed resistance mutations associated only with archived
pre-HAART virus reflecting earlier treatment; HAART-selected mutations
were seen only in patients with viral loads >400 c/mL.
Comment: The study is unique in showing the ability to amplify
HIV in patients with viral loads <50 c/mL to measure resistance
mutations. The results showed that new mutations attributed to selection
by the HAART regimen did not occur, although there were mutations
reflecting antiretroviral therapy that preceded HAART. This paper
supports the conclusions of the clinical study of Havlir and colleagues
that appears in the same issue [JAMA 2001;286:171] in showing
that low level viremia is not associated with selection of resistant
strains. It also shows the potential utility of this technology
as a future method to determine resistance patterns despite low-level
viremia when clinical decisions would benefit from this information.
posted
7/17/2001
|

|